Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 2 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 6Head & Neck 3Dermatologic 3Thoracic 2Gynecologic 2Genitourinary 2Breast 2Sarcoma 1

Conditions

Squamous Cell Carcinoma of Head and Neck 17Head and Neck Neoplasms 10Melanoma 9Carcinoma, Non-Small-Cell Lung 8Neoplasms 6Neoplasm Metastasis 6Urinary Bladder Neoplasms 5Triple Negative Breast Neoplasms 5Breast Neoplasms 5Uterine Cervical Neoplasms 4Stomach Neoplasms 4Ovarian Neoplasms 4Mouth Neoplasms 4Colorectal Neoplasms 4Carcinoma, Merkel Cell 4Carcinoma, Hepatocellular 4Pancreatic Neoplasms 3Oropharyngeal Neoplasms 3Laryngeal Neoplasms 3Colonic Neoplasms 3Thyroid Neoplasms 2Thyroid Carcinoma, Anaplastic 2Sarcoma 2Recurrence 2Prostatic Neoplasms 2Kidney Neoplasms 2Gastrointestinal Neoplasms 2Carcinoma, Squamous Cell 2Carcinoma, Renal Cell 2Carcinoma 2

Interventions

pembrolizumab 7Cetuximab 5selpercatinib 3cemiplimab 3Trastuzumab 3Magnetic Resonance Spectroscopy 3Gemcitabine 3Erlotinib Hydrochloride 3Bortezomib 3sargramostim 2motexafin gadolinium 2entinostat 2Specimen Handling 2Radiotherapy 2Oxaliplatin 2Irinotecan 2Fluorodeoxyglucose F18 2Drug Therapy 2Docetaxel 2Biopsy 2ulixertinib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1trametinib 1tislelizumab 1tipifarnib 1tanespimycin 1spartalizumab 1serabelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Colonic Neoplasms × cemiplimab × Head & Neck × Clear all
NCT05259696 2025-08-20

GLIMMER-01

Palleon Pharmaceuticals, Inc.

Phase 1/2 Completed
69 enrolled 13 charts
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Head and Neck Neoplasms, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT05864144 2025-08-15

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Sensei Biotherapeutics, Inc.

Phase 1/2 Active not recruiting
98 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Uterine Neoplasms, Carcinoma, Merkel Cell

NCT04291105 2025-03-26

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

Vyriad, Inc.

Phase 2 Recruiting
87 enrolled
DermatologicGastrointestinalHead & Neck

Squamous Cell Carcinoma of Head and Neck, Colonic Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡